Vortioxetine for Menopausal Depression and Associated Symptoms
Phase of Trial: Phase IV
Latest Information Update: 08 May 2017
Price : $35 *
At a glance
- Drugs Vortioxetine (Primary)
- Indications Depressive disorders; Menopause
- Focus Therapeutic Use
- 21 Mar 2017 Status changed from recruiting to completed.
- 16 Mar 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2016 as per ClinicalTrials.gov record.
- 29 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.